Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Beroni Group, an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug manufacture contract with Aurigene Pharmaceutical ...
read more
Hovione Technology has secured global rights to develop and commercialize a new ultra-affordable, multi-use blister-based dry powder inhaler patented by inventor Dr. Klaus-Dieter Beller.
read more
Wednesday, September 04, 2019
The FDA has issued a Complete Response Letter for the New Drug Application for Insulin Glargine filed by the company’s partner, Mylan.
read more
Thursday, October 31, 2019
Parexel announced the expansion of its collaboration with the Society for Clinical Research Sites (SCRS).
read more
Tuesday, February 18, 2014
Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, announces an enhancement to its ThermoTrek™ range of solutions. They now feature ThermoCline Technology™ (TCT) allowing 48 plus hours ...
read more
Thursday, December 28, 2017
Integrity Applications has entered into an exclusive distribution agreement with MediReva for the GlucoTrack in the Netherlands.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Fujifilm will acquire the shares of Biogen’s subsidiary, which holds Biogen’s biologics manufacturing operations in Hillerød, Denmark.
read more
Thursday, January 19, 2023
Cambrex has completed its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
Wednesday, January 05, 2022
Dipharma Francis, a global CDMO and a manufacturer of APIs and intermediates for generic and contract manufacturing markets, is announced that Kalexsyn, Inc., a Michigan corporation acquired in 2018, has been merged into its 100% owner, Dipharma Inc....
read more
Samsung Biologics signed an agreement with the Incheon Free Economic Zone (IFEZ) on July 18th to build out its second Bio Campus.
read more
Societal CDMO has been awarded CDMO service contracts from three new customers. The agreements include clinical trial services, analytical method and formulation development, and cGMP manufacturing.
read more
Aurisco Pharmaceutical announced the expansion of its oligonucleotide manufacturing capacity and a new edition of its corporate website – www.aurisco.com.
read more
Thursday, September 21, 2023
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive ...
read more
Astellas Pharma Inc. and DigiTx Partners LLC announced that Astellas has launched DigiTx Partners, a digital health investment company in partnership with MPM Capital, Inc. DigiTx Partners will invest in the digital health space broadly, with a ...
read more